La résistance de Onchocerca volvulus à livermectine: une éventualité à considérer

Anderson, 1991 Arena, 1992, Expression of a glutamate-activated chloride current in Xenopus oocytes injected with Caenorhabditis elegans RNA: evidence for modulation with ivermectin, Mol. Brain Res., 15, 339, 10.1016/0169-328X(92)90127-W Arena, 1995, The mechanism of action of avermectins in Caenorhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity, J. Parasitol., 81, 286, 10.2307/3283936 Avery, 1990, Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans, J. Exp. Zool., 253, 263, 10.1002/jez.1402530305 Awadzi, 1995, The chemotherapy of onchocerciasis XIX: the clinical and laboratory tolerance of high dose ivermectin, Trop. Med. Parasitol., 46, 131 Barnes, 1995, Worm control and anthelminthic resistance: adventures with a model, Parasitol. Today, 11, 56, 10.1016/0169-4758(95)80117-0 Barnes, 1997, The Caenorhabditis elegans avermectin resistance and anesthesic response gene unc-9 encodes a member of a protein family implicated in electrical coupling of excitable cells, J. Neurochem., 69, 2251, 10.1046/j.1471-4159.1997.69062251.x Bennett, 1986, Micromotility meter: an instrument designed to evaluate the action of drugs on motility of larval and adult nematodes, Parasitology, 93, 341, 10.1017/S0031182000051507 Blackhall, 1998, Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus, Mol. Biochem. Parasitol., 95, 193, 10.1016/S0166-6851(98)00087-5 Blackhall, 1998, Haemonchus contortus: selection at a glutamate-gated chloride channel gene in ivermectin- and moxidectin-selected strains, Exp. Parasitol., 90, 42, 10.1006/expr.1998.4316 Boussinesq, 1995, Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in Northern Cameroon, Am. J. Trop. Med. Hyg., 53, 63 Boussinesq, 1998, Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis, Am. J. Trop. Med. Hyg., 58, 461, 10.4269/ajtmh.1998.58.461 Boussinesq, 1998, La lutte contre l'onchocercose en Afrique: aspects actuels, Méd. Trop., 58, 285 Breton, 1997, Ivermectin and moxidectin in two filarial systems: resistance of Monanema martini; inhibition of Litomosoides sigmondontis insemination, Parassitologia, 39, 19 Broeks, 1995, A P-glycoprotein protects Caenorhabditis elegans against natural toxins, EMBO J., 14, 1858, 10.1002/j.1460-2075.1995.tb07178.x Brownlee, 1997, Actions of the anthelmintic ivermectin on the pharyngeal muscle of the parasitic nematode, Ascaris suum, Parasitology, 115, 553, 10.1017/S0031182097001601 Chavasse, 1990, In vitro effects of ivermectin on Onchocerca volvulus microfilariae assessed by observation and by inoculation into Simulium damnosum sensu lato, Trans. R. Soc. Trop. Med. Hyg., 84, 707, 10.1016/0035-9203(90)90157-A Comins, 1977, The development of insecticide resistance in the presence of migration, J. Theor. Biol., 64, 177, 10.1016/0022-5193(77)90119-9 Comley, 1989, Colorimetric quantitation of filarial viability, Int. J. Parasitol., 19, 77, 10.1016/0020-7519(89)90024-6 Conder, 1995, Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance, Adv. Parasitol., 35, 1, 10.1016/S0065-308X(08)60069-X Conder, 1993, Demonstration of co-resistance of Haemonchus contortus to ivermectin and moxidectin, Vet. Rec., 132, 651, 10.1136/vr.132.26.651 Cully, 1994, Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans, Nature, 371, 707, 10.1038/371707a0 Cully, 1996, Molecular biology and electrophysiology of glutamate-gated chloride channels of invertebrates, Parasitology, 113, S191, 10.1017/S0031182000077970 De Clercq, 1997, Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali, Am. J. Trop. Med. Hyg., 57, 25, 10.4269/ajtmh.1997.57.25 Dent, 1997, avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans, EMBO J, 16, 5867, 10.1093/emboj/16.19.5867 Didier, 1996, The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor, Anti-Cancer Drugs, 7, 745, 10.1097/00001813-199609000-00005 Dobson, 1996, Management of anthelminthic resistance: inheritance of resistance and selection with persistent drugs, Int. J. Parasitol., 26, 993, 10.1016/S0020-7519(96)80078-6 Echevarria, 1992, Isoenzyme analysis of Haemonchus contortus resistant or susceptible to ivermectin, Vet. Parasitol., 44, 87, 10.1016/0304-4017(92)90146-Z Foote, 1994, The mode of action and mechanism of resistance to antimalarial drugs, Acta Trop., 56, 157, 10.1016/0001-706X(94)90061-2 Gardon, 1997, Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection, Lancet, 350, 18, 10.1016/S0140-6736(96)11094-1 Geary, 1993, Haemonchus contortus: ivermectin-induced paralysis of the pharynx, Exp. Parasitol., 77, 88, 10.1006/expr.1993.1064 Geerts, 1997, Anthelmintic resistance in human helminths: learning from the problems with worm control in livestock, Parasitol. Today, 13, 149, 10.1016/S0169-4758(97)01024-7 Gill, 1998, Evidence of multiple mechanisms of avermectin resistance in Haemonchus contortus — comparison of selection protocols, Int. J. Parasitol., 28, 783, 10.1016/S0020-7519(98)00015-0 Gill, 1993, In vitro activity of paraherquamide against the free-living stages of Haemonchus contortus, Trichostrongylus colubriformis and Ostertagia circumcincta, Int. J. Parasitol., 23, 375, 10.1016/0020-7519(93)90013-O Gill, 1998, Avermectin/milbemycin resistance in trichostrongyloid nematodes, Int. J. Parasitol., 28, 863, 10.1016/S0020-7519(98)00068-X Gill, 1991, Detection of resistance to ivermectin in Haemonchus contortus, Int. J. Parasitol., 21, 771, 10.1016/0020-7519(91)90144-V Gill, 1995, Avermectin inhibition of larval development in Haemonchus contortus — effects of ivermectin resistance, Int. J. Parasitol., 25, 463, 10.1016/0020-7519(94)00087-5 Grant, 1994, Genetic variation in parasitic nematodes and its implications, Int. J. Parasitol., 24, 821, 10.1016/0020-7519(94)90008-6 Kotze, 1998, Effects of macrocyclic lactones on ingestion in susceptible and resistant Haemonchus contortus larvae, J. Parasitol., 84, 631, 10.2307/3284740 Kwa, 1998, Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus, Int. J. Parasitol., 28, 1235, 10.1016/S0020-7519(98)00071-X Laughton, 1997, Reporter gene constructs suggest that the Caenorhabditis elegans avermectin receptor β-subunit is expressed solely in the pharynx, J. Exp. Biol., 200, 1509, 10.1242/jeb.200.10.1509 Laughton, 1997, Alternative splicing of a Caenorhabditis elegans gene produces two novel inhibitory amino acid receptor subunits with identical ligand binding domains but different ion channels, Gene, 201, 119, 10.1016/S0378-1119(97)00436-8 Laughton, 1995, The β-subunit of Caenorhabditis elegans avermectin receptor responds to glycine and is encoded by chromosome 1, J. Neurochem., 64, 2354, 10.1046/j.1471-4159.1995.64052354.x Lejambre, 1993, Ivermectin-resistant Haemonchus contortus in Australia, Aust. Vet. J., 70, 357, 10.1111/j.1751-0813.1993.tb00887.x Lejambre, 1995, Characterisation of an avermectin resistant isolate of Australian Haemonchus contortus, Int. J. Parasitol., 25, 691, 10.1016/0020-7519(94)00200-8 Lincke, 1992, The P-glycoprotein family of Caenorhabditis elegans. Cloning and characterization of genomic and complementary DNA sequences, J. Mol. Biol., 228, 701, 10.1016/0022-2836(92)90855-E Martin, 1996, An electrophysiological preparation of Ascaris suum pharyngeal muscle reveals a glutamate-gated chloride channel sensitive to the avermectin analogue, milbemycin D, Parasitology, 112, 247, 10.1017/S0031182000084833 Martin, 1989, A patchclamp study of effects of dihydroavermectin on Ascaris muscle, Br. J. Pharmacol., 98, 747, 10.1111/j.1476-5381.1989.tb14602.x Molyneux, 1997, Onchocerciasis control: moving towards the millenium, Parasitol. Today, 13, 418, 10.1016/S0169-4758(97)00142-7 Mukherjee, 1998, Development of in vitro screening system for assessment of antifilarial activity of compounds, Acta Trop., 70, 251, 10.1016/S0001-706X(98)00016-3 Plaisier, 1990, ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis, Comp. Meth. Prog. Biomed., 31, 43, 10.1016/0169-2607(90)90030-D Pouliot, 1997, Reversal of P-glycoprotein-associated multidrug resistance by ivermectin, Biochem. Pharmacol., 10, 17, 10.1016/S0006-2952(96)00656-9 Rand, 1995, Genetic pharmacology: interactions between drugs and gene products in Caenorhabditis elegans, vol. 48, 187 Remme, 1995, The African Programme for onchocerciasis Control: preparing to launch, Parasitol. Today, 11, 403, 10.1016/0169-4758(95)80017-4 Richards, 1995, In vitro studies on the relative sensitivity to ivermectin of Necator americanus and Ancylostoma ceylanicum, Int. J. Parasitol., 25, 1185, 10.1016/0020-7519(95)00036-2 Rohrer, 1994, Ivermectin binding sites in sensitive and resistant Haemonchus contortus, J. Parasitol., 80, 493, 10.2307/3283426 Roos, 1995, New genetic and practical implications of selection for anthelmintic resistance in parasitic nematodes, Parasitol. Today, 11, 148, 10.1016/0169-4758(95)80136-7 Sangster, 1996, Pharmacology of anthelmintic resistance, Parasitology, 113, S201, 10.1017/S0031182000077982 Schinkel, 1994, Disruption of the mouse mar1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell, 77, 491, 10.1016/0092-8674(94)90212-7 Shoop, 1993, Ivermectin resistance, Parasitol. Today, 9, 154, 10.1016/0169-4758(93)90136-4 Shoop, 1993, Mutual resistance to avermectins and milbemycins: oral activity of ivermectin and moxidectin against ivermectin-resistant and susceptible nematodes, Vet. Rec., 133, 445, 10.1136/vr.133.18.445 Shoop, 1995, Structure and activity of avermectins and milbemycins in animal health, Vet. Parasitol., 59, 139, 10.1016/0304-4017(94)00743-V Strote, 1993, Viability of Onchocerca volvulus in vitro, Parasitology, 107, 175, 10.1017/S0031182000067287 Strote, 1996, The ultrastructure of the anterior end of male Onchocerca volvulus: papillae, amphids, nerve ring and first indication of an excretory system in the adult filarial worm, Parasitology, 113, 71, 10.1017/S0031182000066294 Sutherland, 1988, Detection of benzimidazole resistance in trichostrongylid nematodes, Parasitol. Today, 4, 22, 10.1016/0169-4758(88)90055-5 Tagboto, 1996, Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo, Ann. Trop. Med. Parasitol., 90, 497, 10.1080/00034983.1996.11813075 Tagboto, 1994, Comparison of the sensitivity of different geographical isolates of Onchocerca volvulus microfilariae to ivermectin: effects of exposure to drug on development in the blackfly Simulium ornatum, Trans. R. Soc. Trop. Med. Hyg., 88, 237, 10.1016/0035-9203(94)90313-1 Thompson, 1996, Prospects for rational approaches to anthelmintic discovery, Parasitology, 113, S217, 10.1017/S0031182000077994 Townson, 1991, The effects of ivermectin on the viability of Onchocerca lienalis microfilariae in vitro and on their subsequent development in the blackfly vector, Simulium ornatum, Trop. Med. Paraitol., 42, 31 Townson, 1994, Comparison of the sensitivity of different geographical races of Onchocerca volvulus microfilariae to ivermectin: studies in vitro, Trans. R. Soc. Trop. Med. Hyg., 88, 101, 10.1016/0035-9203(94)90521-5 Trees, 1998, Animal models — Onchocerca ochengi and the development of chemtherapeutic and chemoprophylactic agents for onchocerciasis, Ann. Trop. Med. Parasitol., 92, S175, 10.1080/00034989859799 Vassilatis, 1997, Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel en Caenorhabditis elegans. Isolation and characterization, J. Biol. Chem., 272, 33167, 10.1074/jbc.272.52.33167 Wood, 1981, Insecticide resistance: populations and evolution, 97 Xu, 1998, Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog, Mol. Biochem. Parasitol., 91, 327, 10.1016/S0166-6851(97)00215-6